Anti-Mullerian Hormone Changes After Laparoscopic Ovarian Cystectomy for Endometrioma Compared With the Non-ovarian Conditions
NCT ID: NCT01919333
Last Updated: 2013-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
56 participants
OBSERVATIONAL
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laparoscopic ovarian cystectomy
the group who laparoscopic ovarian cystectomy are performed for endometrioma
No interventions assigned to this group
laparoscopic non- ovarian pelvic surgery
the group whom laparoscopic non- ovarian pelvic surgery are performed
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Every participants have to completely understand the process of this study and have written informed consent .
* Having regular menstrual cycles (21-35 days) at the time of operation
* no evidence of any other endocrine disorders such as diabetes mellitus, thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, or adrenal insufficiency.
* undergo laparoscopic ovarian cystectomy or laparoscopic non- ovarian pelvic surgery for benign pelvic disease
* No previous history of adnexal surgery
* No any suspicious findings of malignant ovarian diseases
* Never taking any medication such as oral pill and hormonal drugs within 3 months before the enrollment.
* pathological diagnosis of excised ovarian tissue confirm as endometriotic cyst in study group and other benign pelvic disease in control group
Exclusion Criteria
* pathological report as the malignant diseases
* have operation conversion to open-laparotomy
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thammasat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chamnan Tanprasertkul
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine , Thammasat university
Rangsit City Municipality, Pathumthanee, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chamnan Tanprasertkul
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MTU-OB-3-096/56
Identifier Type: -
Identifier Source: org_study_id